NCT02888743 2026-03-19
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
Blokhin's Russian Cancer Research Center
Memorial Sloan Kettering Cancer Center
DEKA Biosciences
Sun Yat-sen University